首页 › 基金 › DIADEMA PARTNERS LP › BIIB
DIADEMA PARTNERS LP 对 BIIB 的持仓历史
BIOGEN INC · 医疗保健
DIADEMA PARTNERS LP 在 Q2 2026 的 13F 申报中披露持有 BIIB(BIOGEN INC)60,000 股,市值约 US$13.0M,约占其申报组合的 2.82%,在其申报持仓中市值排名第 11 位。 DIADEMA PARTNERS LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
DIADEMA PARTNERS LP 对 BIIB 的持仓演变
DIADEMA PARTNERS LP 于 Q2 2026 首次披露 BIIB 持仓:60,000 股(约 US$13.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 60.00K | $12.96M | 新进 |
关于 BIIB 与 13F 数据
BIIB(BIOGEN INC)属于医疗保健行业。我们追踪的基金中还有 22 只申报持有 BIIB,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$3.27B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 DIADEMA PARTNERS LP
常见问题
How long has DIADEMA PARTNERS LP held BIIB?
DIADEMA PARTNERS LP has disclosed BIIB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is DIADEMA PARTNERS LP's current position in BIIB?
As of Q2 2026, DIADEMA PARTNERS LP holds 60.00K shares of BIIB (BIOGEN INC), valued at $12.96M, representing 2.82% of its reported portfolio and ranking #11.
Has DIADEMA PARTNERS LP been buying or selling BIIB?
In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP newly opened its position in BIIB.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.